Otten N, Hall K, Irvine-Meek J, Leroux M, Budnik D, Seshia S
Can J Neurol Sci. 1984 Nov;11(4):457-60. doi: 10.1017/s031716710004600x.
Free and total valproic acid (VPA) pharmacokinetic evaluation was carried out at steady state in six young epileptics who were also receiving other anticonvulsants. Subjects received their usual morning dose of VPA after an overnight fast. Blood samples for free and total VPA were taken prior to the dose and frequently thereafter for 12 hours. The calculated pharmacokinetic parameters for total VPA and free VPA were: half-lives of 7.5 +/- 1.6 hours and 5.0 +/- 1.5 hours, volumes of distribution of 0.189 +/- 0.038 l/kg and 1.51 +/- 0.98 l/kg, and clearances of 0.30 +/- 0.06 and 3.6 +/- 2.0 ml/min/kg., respectively. There was a strong correlation between percent free VPA and total VPA (r = 0.81) but marked inter- and intra-subject variations were seen. Studies attempting to correlate VPA levels to clinical response must take such data into account.
在6名同时服用其他抗惊厥药物的年轻癫痫患者中,在稳态下进行了游离和总丙戊酸(VPA)的药代动力学评估。受试者在禁食过夜后服用其通常的早晨剂量的VPA。在给药前以及给药后12小时内频繁采集用于检测游离和总VPA的血样。总VPA和游离VPA的计算药代动力学参数分别为:半衰期7.5±1.6小时和5.0±1.5小时,分布容积0.189±0.038 l/kg和1.51±0.98 l/kg,清除率0.30±0.06和3.6±2.0 ml/min/kg。游离VPA百分比与总VPA之间存在强相关性(r = 0.81),但受试者间和受试者内均存在明显差异。试图将VPA水平与临床反应相关联的研究必须考虑此类数据。